Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 7/19/2024Rona Thera Raises $35M Series A+ Financing to Advance Innovative Metab...
  • 7/19/2024ExoNeuglia Secures Investment to Advance Clinical Trials for Neurodege...
  • 7/18/2024China Sets Up National Working Group to Standardize Healthcare Securit...
  • 7/18/2024Merck Unveils GMP-Compliant Cell Culture Media Manufacturing Line in C...
  • 7/18/2024Marinus's Ganaxolone Approved in China as First Treatment for Seizures...
  • 7/18/2024India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
  • 7/18/2024NMPA Suspends Import, Sales and Use of Daiwoong's Cefodizime Sodium fo...
  • 7/18/2024NMPA Solicits Public Comments on Drafts of the 'GMP for Pharmaceutical...
  • 7/17/2024CDE Issues the Technical Guidelines for Clinical Trials of Drugs for G...
  • 7/17/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 7/17/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...
  • 7/17/2024Green Cross Sells Hong Kong Unit to China Resources Boya Bio
  • 7/17/2024SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to E...
  • 7/17/2024Full-Life Tech, SK Biopharma Enter Licensing Deal for Novel Therapeuti...
  • 7/16/2024U.S. Senators Introduce Bill to Reduce U.S. Dependence on China for Ph...
  • 7/16/2024NMPA Announces Package Insert Revision of Spleen Polypeptide Injection...
  • 7/15/2024GenScript's US Unit Legend Biotech Reportedly Receives Takeover Approa...
  • 7/15/2024Domestic Developers File for China's First Home-Made Quadrivalent HPV ...
  • 7/15/2024CDE Solicits Comments on the Technical Guidelines for IVRT and IVPT St...
  • 7/12/2024Recent Executive Moves
  • 7/12/2024NMPA Clears CSPC's RSV Vaccine Candidate for Human Clinical Trials
  • 7/12/2024CDE Solicits Public Comments on ICH M14 and Its Chinese Translation
  • 7/12/2024AFT in China Distribution Deal with Hainan Haiyao for Skin Infection C...
  • 7/11/2024Recent Advancements and Challenges in Cervical Cancer Prevention in Ch...
  • 7/11/2024AusperBio AHB-137 Gains Breakthrough Status in China for CHB  
  • 7/11/2024Sichuan Biokin Pharma Files for US$500M Hong Kong IPO
  • 7/11/2024Ipsen and ForeseenBio Strike Global Licensing Deal for ADCs with FIC...
  • 7/11/2024Elevar and Hengrui Aim for Quick Refile of PD-1 Liver Cancer Combo Aft...
  • 7/11/2024Eisai's Alzheimer's Drug LEQEMBI (Lecanemab) Approved in Hong Kong
  • 7/10/2024China to DeepenHealthcare Reform in 2024
  • Page:26/42 Total number of articles:1234: [First][<<] [24] [25] [26] [27] [28] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group